These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8725310)

  • 1. Syncope in dilated cardiomyopathy is a predictor of sudden cardiac death.
    Fruhwald FM; Eber B; Schumacher M; Zweiker R; Watzinger N; Klein WW
    Cardiology; 1996; 87(3):177-80. PubMed ID: 8725310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
    Zecchin M; Di Lenarda A; Proclemer A; Faganello G; Facchin D; Petz E; Sinagra G
    Europace; 2004 Sep; 6(5):400-6. PubMed ID: 15294264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.
    Kadish A; Dyer A; Daubert JP; Quigg R; Estes NA; Anderson KP; Calkins H; Hoch D; Goldberger J; Shalaby A; Sanders WE; Schaechter A; Levine JH;
    N Engl J Med; 2004 May; 350(21):2151-8. PubMed ID: 15152060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk stratification and long-term therapy with amiodarone in patients with idiopathic dilated cardiomyopathy].
    Zehender M; Faber T; Furtwängler A; Hohnloser S; Meinertz T; Just H
    Z Kardiol; 1992 Dec; 81(12):704-9. PubMed ID: 1492440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Causes and prognosis of syncope in patients with primary dilated cardiomyopathy].
    Brembilla-Perrot B; Suty-Selton C; Beurrier D; Houriez P; Nippert M; Terrier de la Chaise A; Louis P; Claudon O; Blangy H; Juillière Y
    Arch Mal Coeur Vaiss; 2004 Dec; 97(12):1200-5. PubMed ID: 15669361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope.
    Middlekauff HR; Stevenson WG; Stevenson LW; Saxon LA
    J Am Coll Cardiol; 1993 Jan; 21(1):110-6. PubMed ID: 8417050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trials of prophylactic implantable defibrillator therapy in patients with nonischemic cardiomyopathy: what have we learned and what can we expect from future trials?
    Grimm W
    Card Electrophysiol Rev; 2003 Dec; 7(4):463-7. PubMed ID: 15071276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History.
    Gentile P; Merlo M; Cannatà A; Gobbo M; Artico J; Stolfo D; Gigli M; Ramani F; Barbati G; Pinamonti B; Sinagra G
    J Am Heart Assoc; 2019 Sep; 8(17):e010705. PubMed ID: 31431100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
    Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
    Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dilated cardiomyopathy: a new natural history? The experience of the Italian Multicenter Cardiomyopathy Study (SPIC)].
    Gavazzi A; De Maria R; Porcu M; Beretta L; Casazza F; Castelli G; Luvini M; Parodi O; Recalcati F; Renosto G
    G Ital Cardiol; 1995 Sep; 25(9):1109-25. PubMed ID: 8529848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
    Gatzoulis KA; Vouliotis AI; Tsiachris D; Salourou M; Archontakis S; Dilaveris P; Gialernios T; Arsenos P; Karystinos G; Sideris S; Kallikazaros I; Stefanadis C
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):504-12. PubMed ID: 23588627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prediction of cardiac sympathetic nerve activity and cardiac functional outcome after treatment in patients with dilated cardiomyopathy: examination using dobutamine gated blood pool scintigraphy].
    Kasama S; Toyama T; Hoshizaki H; Oshima S; Taniguchi K; Iwasaki T; Suzuki T; Nagai R
    J Cardiol; 2000 Jul; 36(1):29-35. PubMed ID: 10929263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
    Grimm W; Christ M; Bach J; Müller HH; Maisch B
    Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in mechanisms and outcomes of syncope in patients with coronary disease or idiopathic left ventricular dysfunction as assessed by electrophysiologic testing.
    Brembilla-Perrot B; Suty-Selton C; Beurrier D; Houriez P; Nippert M; de la Chaise AT; Louis P; Claudon O; Andronache M; Abdelaal A; Sadoul N; Juillière Y
    J Am Coll Cardiol; 2004 Aug; 44(3):594-601. PubMed ID: 15358027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictive parameters of occurrence of adequate interventions in patients with implanted cardioverter-defibrillators with or without resynchronisation therapy in primary prevention of sudden cardiac death in dilated cardiomyopathy].
    Lelakowski J; Rydlewska A; Lelakowska M; Pudło J; Piekarz J
    Pol Merkur Lekarski; 2017 Feb; 42(248):65-70. PubMed ID: 28258679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of antiarrhythmia therapy on survival times of 19 clinically healthy Doberman pinschers with dilated cardiomyopathy that experienced syncope, ventricular tachycardia, and sudden death (1985-1998).
    Calvert CA; Brown J
    J Am Anim Hosp Assoc; 2004; 40(1):24-8. PubMed ID: 14736902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.
    Vrtovec B; Poglajen G; Lezaic L; Sever M; Domanovic D; Cernelc P; Socan A; Schrepfer S; Torre-Amione G; Haddad F; Wu JC
    Circ Res; 2013 Jan; 112(1):165-73. PubMed ID: 23065358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of patients with dilated cardiomyopathy in a contemporary Swiss population.
    Vischer A; Osswald S; Sticherling C; Schaer B
    Acta Cardiol; 2009 Jun; 64(3):347-50. PubMed ID: 19593945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.